{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:16:54Z","timestamp":1792023414192,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673436"],"award-info":[{"award-number":["81673436"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673437"],"award-info":[{"award-number":["81673437"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21472091"],"award-info":[{"award-number":["21472091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872877"],"award-info":[{"award-number":["81872877"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011247","name":"State Key Laboratory of Pharmaceutical Biotechnology","doi-asserted-by":"publisher","award":["KF-GN-201703"],"award-info":[{"award-number":["KF-GN-201703"]}],"id":[{"id":"10.13039\/501100011247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011403","name":"Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica","doi-asserted-by":"publisher","award":["JKLPSE201802"],"award-info":[{"award-number":["JKLPSE201802"]}],"id":[{"id":"10.13039\/501100011403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.apsb.2018.08.009","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:22:26Z","timestamp":1536106946000},"page":"304-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"title":["SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade"],"prefix":"10.1016","volume":"9","author":[{"given":"Mingxia","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3418-9975","authenticated-orcid":false,"given":"Xiangbao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2018.08.009_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2018.08.009_bib2","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2018.08.009_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2015.10.009","article-title":"Immune suppressive mechanisms in the tumor microenvironment","volume":"39","author":"Munn","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.apsb.2018.08.009_bib4","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.4049\/jimmunol.1401572","article-title":"The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity","volume":"193","author":"Ostrand-Rosenberg","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2018.08.009_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2018.08.009_bib6","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-13-1504","article-title":"VISTA is an immune checkpoint molecule for human T cells","volume":"74","author":"Lines","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2018.08.009_bib7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.4049\/jimmunol.0902937","article-title":"T cell Ig and mucin domain proteins and immunity","volume":"184","author":"Kane","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2018.08.009_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/imr.12519","article-title":"LAG3 (CD223) as a cancer immunotherapy target","volume":"276","author":"Andrews","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.apsb.2018.08.009_bib9","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1126\/science.8096088","article-title":"SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases","volume":"259","author":"Feng","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.apsb.2018.08.009_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal structure of the tyrosine phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2018.08.009_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.cr.7290055","article-title":"The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions","volume":"10","author":"Qu","year":"2000","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2018.08.009_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jhep.2018.02.014","article-title":"SHP2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic \u03b2-catenin, PIK3CA and MET","volume":"69","author":"Liu","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2018.08.009_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nm.2645","article-title":"Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop","volume":"18","author":"Aceto","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2018.08.009_bib14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI43690","article-title":"SHP-2\/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A\/ARF aberrations in mice and humans","volume":"121","author":"Liu","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2018.08.009_bib15","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2004-10-4057","article-title":"Overexpression of SHP2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia","volume":"106","author":"Xu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2018.08.009_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nature18621","article-title":"Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases","volume":"535","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2018.08.009_bib17","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/j.1349-7006.2009.01257.x","article-title":"Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation","volume":"100","author":"Matozaki","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.apsb.2018.08.009_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41591-018-0023-9","article-title":"SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo","volume":"24","author":"Mainardi","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2018.08.009_bib19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-018-0024-8","article-title":"Mutant KRAS-driven cancers depend on PTPN11\/SHP2 phosphatase","volume":"24","author":"Ruess","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2018.08.009_bib20","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41591-018-0022-x","article-title":"Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition","volume":"24","author":"Wong","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2018.08.009_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ejmg.2015.08.005","article-title":"SHP2 sails from physiology to pathology","volume":"58","author":"Tajan","year":"2015","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.apsb.2018.08.009_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.it.2006.01.007","article-title":"SHP2 forecast for the immune system: fog gradually clearing","volume":"27","author":"Salmond","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2018.08.009_bib23","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.apsb.2018.08.009_bib24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1158\/0008-5472.CAN-14-1215","article-title":"PD-1\/SHP-2 inhibits Tc1\/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment","volume":"75","author":"Li","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2018.08.009_bib25","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2018.08.009_bib26","doi-asserted-by":"crossref","first-page":"7586","DOI":"10.18632\/oncotarget.13812","article-title":"T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2018.08.009_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.apsb.2016.02.002","article-title":"Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-kappaB pathways","volume":"6","author":"Peng","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2018.08.009_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.apsb.2017.02.005","article-title":"T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model","volume":"7","author":"Sang","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2018.08.009_bib29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jhep.2015.03.036","article-title":"PTPN11\/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients","volume":"63","author":"Han","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2018.08.009_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ni1144","article-title":"B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator","volume":"6","author":"Sedy","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2018.08.009_bib31","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1021\/acs.jmedchem.6b00680","article-title":"Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor","volume":"59","author":"Garcia Fortanet","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2018.08.009_bib32","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3389\/fimmu.2017.01326","article-title":"Ptpn11 deletion in CD4+ cells does not affect T cell development and functions but causes cartilage tumors in a T cell-independent manner","volume":"8","author":"Miah","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2018.08.009_bib33","first-page":"6568","article-title":"T cell activation is reduced by the catalytically inactive form of protein tyrosine phosphatase SHP-2","volume":"8","author":"Dong","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.apsb.2018.08.009_bib34","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.4049\/jimmunol.1201006","article-title":"Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis","volume":"189","author":"Wu","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2018.08.009_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.celrep.2018.03.026","article-title":"Shp-2 is dispensable for establishing T cell exhaustion and for PD-1 signaling in vivo","volume":"23","author":"Rota","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2018.08.009_bib36","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1016\/j.apsb.2024.12.023","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000}}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383518306245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383518306245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:39:07Z","timestamp":1761928747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383518306245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2211383518306245"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2018.08.009","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2018.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}